Embryo Transfer. Complications of attempted introduction of embryo in embryo transfer
Conditions
Interventions
Intervention 1: Control Group:All eligible participants (both intervention and control) received oral estradiol valerate (2 mg
Aburaihan Pharmaceutical Company, Tehran, Iran) at a total daily dose of 6 mg, starting from day 2 or 3 of the menstrual cycle, provided transvaginal ultrasound confirmed an appropriate endometrium an
Aburaihan Pharmaceutical Company, Tehran, Iran). Embryo transfer was then scheduled accordingly. The control group did not receive any additional medications. Intervention 2: Intervention Group 1:Thir
Sponsors
Tehran University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
20 Years to 45 Years
Inclusion criteria
Inclusion criteria: Women ageed 20 to 45 years To have embryo frozen History of one failed frozen embryo transfer HRT embryo transfer cycle
Exclusion criteria
Exclusion criteria: Fresh embryo transfer cycles Frozen embryo transfer for first time Male infertility Patients with endometriosis Presence of hydrosalpinx Presence of a myoma with a compressive effect on the endometrium Presence of endometrial pathology
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Implantation rate. Timepoint: Four weeks after the embryo transfer. Method of measurement: Transvaginal ultrasound.;Chemical pregnancy. Timepoint: Two weeks after the embryo transfer. Method of measurement: Pregnancy blood test (Serum ß-hCG test).;Clinical pregnancy. Timepoint: Four weeks after embryo transfer. Method of measurement: Transvaginal ultrasound. | — |
Secondary
| Measure | Time frame |
|---|---|
| Multiple pregnancy. Timepoint: Four weeks after embryo transfer. Method of measurement: Transvaginal ultrasound.;Miscarriage. Timepoint: From positive pregnancy test up to 20 weeks of gestation. Method of measurement: Transvaginal ultrasound.;Ectopic pregnancy. Timepoint: From four weeks after embryo transfer. Method of measurement: Transvaginal ultrasound. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMahshad Forati Kashani
Tehran University of Medical Sciences
Outcome results
None listed